News

PSI 2024 Conference - Spotlight on our Keynote Session!

Mar 25, 2024, 12:43 PM
Here is what one of your keynote speakers had to say about their session coming up in PSI Conference 2024!

Important lessons should be learned from the COVID pandemic, in terms of preparedness for future pandemics as well as paradigms for more routine clinical trial and epidemiological work. First, the timely availability of high-quality data is crucial, allied with the most appropriate methodology to draw valid conclusions from imperfect and incomplete data. Second, we should reflect on which endpoints to use when conducting, in particular, vaccine trials. Ultimately the way in which they protect from severe infection, requiring hospitalization or ICU admission, and mortality, is what matters. Concerted efforts are needed to evaluate correlates-of-protection. Third, in non-pandemic times, it is crucial to invest in health literacy. Misconceptions arising from Simpson’s paradox in vaccine efficacy over genuine hesitancy to outright conspiracy theory may be the undoing of brilliant clinical and epidemiological research. Arguably, biostatisticians, properly trained in science communication and outreach, are well placed to explain complicated and potentially confusing concepts.
- Geert Molenberghs, PhD

Geert_and_conference logo

Geert will be presenting on Monday 17 June, on the topic of Biostatistics in a post-pandemic era: lessons learned for research, public health, drug and vaccine development, policy advice, and communication.

Upcoming Events

Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

PSI Webinar: Drug Development in Women's Health

The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.

PSI Webinar: Surrogacy

This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.

Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies

Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.

Joint PSI/EFSPI Data Science SIG Webinar: Developing Digital Measures (Digital Biomarkers) in Drug Development – insights from Mobilise D consortium

We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.

PSI Career Young Virtual Event (Q2 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Webinar: Development of Gene Therapies: Strategic, Scientific, Regulatory and Access Considerations

This webinar will cover the history of cell/gene therapy, major regulatory advances, the role of quantitative scientists in drug development of these novel therapeutics, and discuss opportunities for innovation and product advancement.

PSI Career Young Virtual Event (Q3 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

PSI Introduction to Industry Training (ITIT) Course - 2024/2025

An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.

PSI Career Young Virtual Event (Q4 2024)

This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.

Latest Jobs

Statistician, Data Science

We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.